Aberrant glycosylation as biomarker for cancer: Focus on CD43

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Tuccillo, Franca Maria ^a   De Laurentiis, Annamaria ^b   Palmieri, Camillo ^b   Fiume, Giuseppe ^b   Bonelli, Patrizia ^a   Borrelli, Antonella ^a   Tassone, Pierfrancesco ^b   Scala, Iris ^c   Buonaguro, Franco Maria ^a   Quinto, Ileana ^b   Scala, Giuseppe ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; GLYCOPROTEIN; LEUKOSIALIN; MONOCLONAL ANTIBODY; MUCIN; POLYSACCHARIDE; TUMOR MARKER;

GLYCOBIOLOGY; HUMAN; IMMUNOASSAY; NEOPLASM; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; REVIEW; ANIMAL; BLOOD; GLYCOSYLATION; METABOLISM;

ANIMALS; ANTIGENS, CD43; GLYCOSYLATION; HUMANS; MUCINS; NEOPLASMS; POLYSACCHARIDES; TUMOR MARKERS, BIOLOGICAL;

EID: 84896312824     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/742831     Document Type: Review

References (165)

1. Crocker P. R., Feizit T., Carbohydrate recognition systems: functional triads in cell-cell interactions. Current Opinion in Structural Biology 1996 6 5 679 691 2-s2.0-0030271766 10.1016/S0959-440X(96)80036-4 (Pubitemid 26372346)
2. Feizi T., Carbohydrate-mediated recognition systems in innate immunity. Immunological Reviews 2000 173 79 88 2-s2.0-0033954057 10.1034/j.1600-065X.2000. 917310.x (Pubitemid 30095212)
3. Gabius H. J., Siebert H. C., André S., Jiménez-Barbero J., Rüdiger H., Chemical biology of the sugar code. ChemBioChem 2004 5 6 740 764 2-s2.0-3343018656 10.1002/cbic.200300753 (Pubitemid 39257059)
4. Helenius A., Aebi M., Intracellular functions of N-linked glycans. Science 2001 291 5512 2364 2369 2-s2.0-0035937505 10.1126/science.291.5512.2364 (Pubitemid 32231791)
5. Karlsson K., Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Molecular Microbiology 1998 29 1 1 11 2-s2.0-0031872407 10.1046/j.1365-2958.1998.00854.x (Pubitemid 28318557)
6. Lowe J. B., Marth J. D., A genetic approach to mammalian glycan function. Annual Review of Biochemistry 2003 72 643 691 2-s2.0-0042266719 10.1146/annurev.biochem.72.121801.161809 (Pubitemid 36930456)
7. Apweiler R., Hermjakob H., Sharon N., On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochimica et Biophysica Acta 1999 1473 1 4 8 2-s2.0-0032754473 10.1016/S0304-4165(99) 00165-8
8. Spiro R. G., Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. Glycobiology 2002 12 4 43R 56R 2-s2.0-0036019907 (Pubitemid 34760066)
9. Cummings R. D., The repertoire of glycan determinants in the human glycome. Molecular BioSystems 2009 5 10 1087 1104 2-s2.0-70349326274 10.1039/b907931a
10. Varki A., Lowe J. B., Varki A., Cummings R. D., Esko J. D., Freeze H. H., Stanley P., Bertozzi C. R., Hart G. W., Etzler M. E., Biological roles of glycans. Essentials of Glycobiology 2009
11. Varki A., Freeze H. H., Vacquier V. D., Varki A., Cummings R. D., Esko J. D., Freeze H. H., Stanley P., Bertozzi C. R., Hart G. W., Etzler M. E., Glycans in development and systemic physiology. Essentials of Glycobiology 2009
12. Varki A., Kannagi R., Toole B. P., Varki A., Cummings R. D., Esko J. D., Freeze H. H., Stanley P., Bertozzi C. R., Hart G. W., Etzler M. E., Glycosylation changes in cancer. Essentials of Glycobiology 2009
13. Raedler A., Schreiber S., Analysis of differentiation and transformation of cells by lectins. Critical Reviews in Clinical Laboratory Sciences 1988 26 2 153 193 2-s2.0-0024253979
14. Cao Y., Stosiek P., Springer G. F., Karsten U., Thomsen-Friedenreich- related caubohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochemistry and Cell Biology 1996 106 2 197 207 2-s2.0-0029764743 10.1007/s004180050032 (Pubitemid 26281400)
15. Springer G. F., Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy. Journal of Molecular Medicine 1997 75 8 594 602 2-s2.0-0030848719 10.1007/s001090050144 (Pubitemid 27373602)
16. Kumar S. R., Sauter E. R., Quinn T. P., Deutscher S. L., Thomsen-Friedenreich and Tn antigens in nipple fluid: carbohydrate biomarkers for breast cancer detection. Clinical Cancer Research 2005 11 19, part 1 6868 6871 2-s2.0-26444452697 10.1158/1078-0432.CCR-05-0146 (Pubitemid 41428742)
17. Ju T., Wang Y., Aryal R. P., Lehoux S. D., Ding X., Kudelka M. R., Cutler C., Zeng J., Wang J., Sun X., Heimburg-Molinaro J., Smith D. F., Cummings R. D., Tn and sialyl-Tn antigens, aberrant O-glycomics as human disease markers. Proteomics-Clinical Applications 2013 7 9-10 618 631 10.1002/prca.201300024
18. Terasawa K., Furumoto H., Kamada M., Aono T., Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells. Cancer Research 1996 56 9 2229 2232 2-s2.0-0029874714 (Pubitemid 26119930)
19. Kawaguchi T., Takazawa H., Imai S., Morimoto J., Watanabe T., Kanno M., Igarashi S., Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA? Breast Cancer Research and Treatment 2006 98 1 31 43 2-s2.0-33745886837 10.1007/s10549-005-9115-6 (Pubitemid 44050778)
20. Ju T., Lanneau G. S., Gautam T., Wang Y., Xia B., Stowell S. R., Willard M. T., Wang W., Xia J. Y., Zuma R. E., Laszik Z., Benbrook D. M., Hanigan M. H., Cummings R. D., Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. Cancer Research 2008 68 6 1636 1646 10.1158/0008-5472.CAN-07-2345 (Pubitemid 351416547)
21. Pinho S., Marcos N. T., Ferreira B., Carvalho A. S., Oliveira M. J., Santos-Silva F., Harduin-Lepers A., Reis C. A., Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. Cancer Letters 2007 249 2 157 170 2-s2.0-33947423328 10.1016/j.canlet.2006.08.010 (Pubitemid 46452924)
22. Brockhausen I., Yang J., Dickinson N., Ogata S., Itzkowitz S. H., Enzymatic basis for sialyl-Tn expression in human colon cancer cells. Glycoconjugate Journal 1998 15 6 595 603 2-s2.0-0031872786 10.1023/A: 1006967910803 (Pubitemid 28330772)
23. Safi F., Schlosser W., Kolb G., Beger H. G., Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms. Journal of Gastrointestinal Surgery 1997 1 2 106 112 2-s2.0-0346880272 (Pubitemid 127433827)
24. Locker G. Y., Hamilton S., Harris J., Jessup J. M., Kemeny N., Macdonald J. S., Somerfield M. R., Hayes D. F., Bast R. C. Jr., ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Journal of Clinical Oncology 2006 24 33 5313 5327 2-s2.0-33846595479 10.1200/JCO.2006.08.2644 (Pubitemid 46631379)
25. Reiter W., Stieber P., Reuter C., Nagel D., Cramer C., Pahl H., Fateh-Moghadam A., Prognostic value of preoperative serum levels of CEA, CA 19-9 and CA 72-4 in gastric carcinoma. Anticancer Research 1997 17 4 2903 2906 2-s2.0-0030757772 (Pubitemid 27434816)
26. Ychou M., Duffour J., Kramar A., Gourgou S., Grenier J., Clinical significance and prognostic value of CA72-4 compared with CEA and CA19-9 in patients with gastric cancer. Disease Markers 2000 16 3-4 105 110 2-s2.0-0034436640 (Pubitemid 32591564)
27. Duraker N., Elk A. N., The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA. Journal of Surgical Oncology 2001 76 4 266 271 2-s2.0-0035042086 10.1002/jso.1044 (Pubitemid 32381683)
28. Nakamori S., Kameyama M., Imaoka S., Furukawa H., Ishikawa O., Sasaki Y., Kabuto T., Iwanaga T., Matsushita Y., Irimura T., Increased expression of sialyl Lewis(x) antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Research 1993 53 15 3632 3637 2-s2.0-0027250266 (Pubitemid 23229648)
29. Nishihara S., Hiraga T., Ikehara Y., Kudo T., Iwasaki H., Morozumi K., Akamatsu S., Tachikawa T., Narimatsu H., Molecular mechanisms of expression of Lewis b antigen and other type I Lewis antigens in human colorectal cancer. Glycobiology 1999 9 6 607 616 2-s2.0-0033009897 10.1093/glycob/9.6.607 (Pubitemid 29250928)
30. Konno A., Hoshino Y., Terashima S., Motoki R., Kawaguchi T., Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clinical and Experimental Metastasis 2002 19 1 61 70 2-s2.0-0036190078 10.1023/A:1013879702702 (Pubitemid 34208355)
31. Brockhausen I., Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Reports 2006 7 6 599 604 2-s2.0-33744799438 10.1038/sj.embor.7400705 (Pubitemid 43827326)
32. Taniguchi N., Miyoshi E., Ko J. H., Ikeda Y., Ihara Y., Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochimica et Biophysica Acta 1999 1455 2-3 287 300 2-s2.0-0032869011 10.1016/S0925-4439(99)00066-6 (Pubitemid 29435995)
33. Dennis J. W., Laferte S., Waghorne C., β 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987 236 4801 582 585 2-s2.0-0023255440 (Pubitemid 17069927)
34. Noda K., Miyoshi E., Gu J., Gao C., Nakahara S., Kitada T., Honke K., Suzuki K., Yoshihara H., Yoshikawa K., Kawano K., Tonetti M., Kasahara A., Hori M., Hayashi N., Taniguchi N., Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines. Cancer Research 2003 63 19 6282 6289 2-s2.0-0141919565 (Pubitemid 37255175)
35. Miyoshi E., Noda K., Yamaguchi Y., Inoue S., Ikeda Y., Wang W., Ko J. H., Uozumi N., Li W., Taniguchi N., The alpha1-6-fucosyltransferase gene and its biological significance. Biochimica et Biophysica Acta 1999 1473 1 9 20 10.1016/S0304-4165(99)00166-X
36. Ito Y., Miyauchi A., Yoshida H., Uruno T., Nakano K., Takamura Y., Miya A., Kobayashi K., Yokozawa T., Matsuzuka F., Taniguchi N., Matsuura N., Kuma K., Miyoshi E., Expression of α 1,6-fucosyltransferase (FUT8) in papillary carcinoma of the thyroid: its linkage to biological aggressiveness and anaplastic transformation. Cancer Letters 2003 200 2 167 172 2-s2.0-0642335054 10.1016/S0304-3835(03)00383-5 (Pubitemid 38366098)
37. Li D., Mallory T., Satomura S., AFP-L3: a new generation of tumor marker for hepatocellular carcinoma. Clinica Chimica Acta 2001 313 1-2 15 19 2-s2.0-0034749063 10.1016/S0009-8981(01)00644-1 (Pubitemid 33016686)
38. Mungul A., Cooper L., Brockhausen I., Ryder K., Mandel U., Clausen H., Rughetti A., Miles D. W., Taylor-Papadimitriou J., Burchell J. M., Sialylated core 1 based O-linked glycans enhance the growth rate of mammary carcinoma cells in MUC1 transgenic mice. International Journal of Oncology 2004 25 4 937 943 2-s2.0-16644371416
39. Bresalier R. S., Ho S. B., Schoeppner H. L., Kim Y. S., Sleisenger M. H., Brodt P., Byrd J. C., Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology 1996 110 5 1354 1367 2-s2.0-0029863463 10.1053/gast.1996.v110.pm8613039 (Pubitemid 26134066)
40. Hakomori S., Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Advances in Cancer Research 1989 52 257 331 2-s2.0-0024585483 10.1016/S0065-230X(08)60215-8
41. Hakomori S. I., Cummings R. D., Glycosylation effects on cancer development. Glycoconjugate Journal 2012 29 8-9 565 566 10.1007/s10719-012-9448- 4
42. Ohtsubo K., Marth J. D., Glycosylation in cellular mechanisms of health and disease. Cell 2006 126 5 855 867 2-s2.0-33748195979 10.1016/j.cell.2006.08. 019 (Pubitemid 44310784)
43. Do S. I., Kim K., Kim D. H., Chae S. W., Park Y. L., Park C. H., Sohn J. H., Associations between the expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and clinicopathologic parameters of human breast ductal carcinomas. Journal of Breast Cancer 2013 16 2 152 158 10.4048/jbc.2013.16.2.152
44. Kufe D. W., Mucins in cancer: function, prognosis and therapy. Nature Reviews Cancer 2009 9 12 874 885 2-s2.0-70450247207 10.1038/nrc2761
45. Hollingsworth M. A., Swanson B. J., Mucins in cancer: protection and control of the cell surface. Nature Reviews Cancer 2004 4 1 45 60 2-s2.0-0347123435 (Pubitemid 38082153)
46. Kim Y. S., Gum J. Jr., Brockhausen I., Mucin glycoproteins in neoplasia. Glycoconjugate Journal 1996 13 5 693 707 2-s2.0-0029809614 10.1007/BF00702333 (Pubitemid 26354262)
47. Tsuboi S., Hatakeyama S., Ohyama C., Fukuda M., Two opposing roles of O-glycans in tumor metastasis. Trends in Molecular Medicine 2012 18 4 224 232 2-s2.0-84859427921 10.1016/j.molmed.2012.02.001
48. Kjeldsen T., Clausen H., Hirohashi S., Ogawa T., Iijima H., Hakomori S., Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2→6 α -N-acetylgalactosaminyl (sialosyl-Tn) epitope. Cancer Research 1988 48 8 2214 2220 2-s2.0-0023880015
49. Dalziel M., Whitehouse C., McFarlane I., Brockhausen I., Gschmeissner S., Schwientek T., Clausen H., Burchell J. M., Taylor-Papadimitriou J., The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. The Journal of Biological Chemistry 2001 276 14 11007 11015 2-s2.0-0035815609 10.1074/jbc.M006523200 (Pubitemid 38089281)
50. Marcos N. T., Cruz A., Silva F., Almeida R., David L., Mandel U., Clausen H., Von Mensdorff-Pouilly S., Reis C. A., Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines. Journal of Histochemistry and Cytochemistry 2003 51 6 761 771 2-s2.0-0037674996 (Pubitemid 36628857)
51. Tian Y., Zhang H., Characterization of disease-associated N-linked glycoproteins. Proteomics 2013 13 3-4 504 511 10.1002/pmic.201200333
52. Drake R. R., Schwegler E. E., Malik G., Diaz J., Block T., Mehta A., Semmes O. J., Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Molecular and Cellular Proteomics 2006 5 10 1957 1967 2-s2.0-33750620940 10.1074/mcp.M600176-MCP200 (Pubitemid 44688203)
53. Ishihara T., Fukuda I., Morita A., Takinami Y., Okamoto H., Nishimura S., Numata Y., Development of quantitative plasma N-glycoproteomics using label-free 2-D LC-MALDI MS and its applicability for biomarker discovery in hepatocellular carcinoma. Journal of Proteomics 2011 74 10 2159 2168 2-s2.0-80052024809 10.1016/j.jprot.2011.06.010
54. Zeng X., Hood B. L., Sun M., Conrads T. P., Day R. S., Weissfeld J. L., Siegfried J. M., Bigbee W. L., Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry. Journal of Proteome Research 2010 9 12 6440 6449 2-s2.0-78649861704 10.1021/pr100696n
55. Tian Y., Yao Z., Roden R. B. S., Zhang H., Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics. Proteomics 2011 11 24 4677 4687 2-s2.0-82955161671 10.1002/pmic.201000811
56. Chen R., Tan Y., Wang M., Wang F., Yao Z., Dong L., Ye M., Wang H., Zou H., Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma. Molecular & Cellular Proteomics 2011 10 7 M110.006445 2-s2.0-79960177699 10.1074/mcp.M110.006445
57. Tian Y., Bova G. S., Zhang H., Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer. Analytical Chemistry 2011 83 18 7013 7019 2-s2.0-80052805542 10.1021/ac200815q
58. Zhao Y., Sato Y., Isaji T., Fukuda T., Matsumoto A., Miyoshi E., Gu J., Taniguchi N., Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS Journal 2008 275 9 1939 1948 2-s2.0-42449143890 10.1111/j.1742-4658.2008.06346.x (Pubitemid 351569538)
59. Schachter H., Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Advances in Experimental Medicine and Biology 1986 205 53 85 2-s2.0-0022960932
60. Yoshimura M., Nishikawa A., Ihara Y., Taniguchi S., Taniguchi N., Suppression of lung metastasis of B16 mouse melanoma by N- acetylglucosaminyltransferase III gene transfection. Proceedings of the National Academy of Sciences of the United States of America 1995 92 19 8754 8758 2-s2.0-0029027831 10.1073/pnas.92.19.8754
61. Lee S. H., Takahashi M., Honke K., Miyoshi E., Osumi D., Sakiyama H., Ekuni A., Wang X., Inoue S., Gu J., Kadomatsu K., Taniguchi N., Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factor-binding protein 3 in Fut8-/- mice. Journal of Biochemistry 2006 139 3 391 398 2-s2.0-33646355723 10.1093/jb/mvj039 (Pubitemid 43667103)
62. Shibukawa Y., Takahashi M., Laffont I., Honke K., Taniguchi N., Down-regulation of hydrogen peroxide-induced PKC δ activation in N-acetylglucosaminyltransferase III-transfected HeLaS3 cells. The Journal of Biological Chemistry 2003 278 5 3197 3203 2-s2.0-0037474262 10.1074/jbc. M207870200 (Pubitemid 36801230)
63. Nadanaka S., Sato C., Kitajima K., Katagiri K., Irie S., Yamagata T., Occurrence of oligosialic acids on integrin α 5 subunit and their involvement in cell adhesion to fibronectin. The Journal of Biological Chemistry 2001 276 36 33657 33664 2-s2.0-0035823508 10.1074/jbc.M011100200
64. Miyoshi E., Terao M., Kamada Y., Physiological roles of N-acetylglucosaminyltransferase V(GnT-V) in mice. BMB Reports 2012 45 10 554 559 10.5483/BMBRep.2012.45.10.190
65. Lau K. S., Dennis J. W., N-Glycans in cancer progression. Glycobiology 2008 18 10 750 760 2-s2.0-53049084874 10.1093/glycob/cwn071
66. Yin B. W. T., Lloyd K. O., Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. The Journal of Biological Chemistry 2001 276 29 27371 27375 2-s2.0-0035920171 10.1074/jbc.M103554200
67. Nustad K., Bast R. C. Jr., O'Brien T. J., Nilsson O., Seguin P., Suresh M. R., Saga T., Nozawa S., Børmer O. P., de Bruijn H. W. A., Nap M., Vitali A., Gadnell M., Clark J., Shigemasa K., Karlsson B., Kreutz F. T., Jette D., Sakahara H., Endo K., Paus E., Warren D., Hammarström S., Kenemans P., Hilgers J., Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. Tumor Biology 1996 17 4 196 219 2-s2.0-8944237522 (Pubitemid 26227618)
68. O'Brien T. J., Beard J. B., Underwood L. J., Dennis R. A., Santin A. D., York L., The CA 125 gene: an extracellular superstructure dominated by repeat sequences. Tumor Biology 2001 22 6 348 366 2-s2.0-0035689033 10.1159/000050638 (Pubitemid 34062947)
69. Yin B. W. T., Dnistrian A., Lloyd K. O., Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. International Journal of Cancer 2002 98 5 737 740 2-s2.0-0037051691 10.1002/ijc.10250 (Pubitemid 34225625)
70. Chang A., Cai J., Miranda G., Groshen S., Skinner D., Stein J. P., Usefulness of CA 125 as a preoperative prognostic marker for transitional cell carcinoma of the bladder. Journal of Urology 2004 172 6, part 1 2182 2186 2-s2.0-8644287369 10.1097/01.ju.0000143487.20280.ed (Pubitemid 39507487)
71. Schneider J., Tumor markers in detection of lung cancer. Advances in Clinical Chemistry 2006 42 1 41 2-s2.0-33748064683 10.1016/S0065-2423(06)42001-1 (Pubitemid 44302105)
72. Baskić D., Ristić P., Matić S., Banković D., Popović S., Arsenijević N., Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer. Biomarkers 2007 12 6 657 667 2-s2.0-35748976558 10.1080/13547500701520563 (Pubitemid 350048080)
73. Sevinc A., Adli M., Kalender M. E., Camci C., Benign causes of increased serum CA-125 concentration. The Lancet Oncology 2007 8 12 1054 1055 2-s2.0-36549042456 10.1016/S1470-2045(07)70357-1 (Pubitemid 350182965)
74. Harris L., Fritsche H., Mennel R., Norton L., Ravdin P., Taube S., Somerfield M. R., Hayes D. F., Bast R. C. Jr., American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer. Journal of Clinical Oncology 2007 25 33 5287 5312 2-s2.0-36849069347 10.1200/JCO.2007.14.2364 (Pubitemid 350232263)
75. Zurawski V. R. Jr., Orjaseter H., Andersen A., Jellum E., Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. International Journal of Cancer 1988 42 5 677 680 2-s2.0-0024232965 (Pubitemid 19008906)
76. Bast R. C. Jr., Klug T. L., St John E., Jenison E., Niloff J. M., Lazarus H., Berkowitz R. S., Leavitt T., Griffiths C. T., Parker L., Zurawski V. R. Jr., Knapp R. C., A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. The New England Journal of Medicine 1983 309 15 883 887 2-s2.0-0020559574 (Pubitemid 13014028)
77. Pauler D. K., Menon U., McIntosh M., Symecko H. L., Skates S. J., Jacobs I. J., Factors influencing serum CA125II levels in healthy postmenopausal women. Cancer Epidemiology Biomarkers and Prevention 2001 10 5 489 493 2-s2.0-0034921718 (Pubitemid 32701635)
78. Gostout B. S., Brewer M. A., Guidelines for referral of the patient with an adnexal mass. Clinical Obstetrics and Gynecology 2006 49 3 448 458 2-s2.0-33746836162 10.1097/00003081-200609000-00005 (Pubitemid 44181418)
79. Bast R. C. Jr., Badgwell D., Lu Z., Marquez R., Rosen D., Liu J., Baggerly K. A., Atkinson E. N., Skates S., Zhang Z., Lokshin A., Menon U., Jacobs I., Lu K., New tumor markers: CA125 and beyond. International Journal of Gynecological Cancer 2005 15 6 274 281 2-s2.0-30744470421 (Pubitemid 43096594)
80. Ebeling F. G., Stieber P., Untch M., Nagel D., Konecny G. E., Schmitt U. M., Fateh-Moghadam A., Seidel D., Serum CEA and CA 15-3 as prognostic factors in primary breast cancer. The British Journal of Cancer 2002 86 8 1217 1222 2-s2.0-0037156936 10.1038/sj.bjc.6600248
81. Kumpulainen E. J., Keskikuru R. J., Johansson R. T., Serum tumor marker CA 15.3 and stage are the two most powerful predictors of survival in primary breast cancer. Breast Cancer Research and Treatment 2002 76 2 95 102 2-s2.0-0036828534 10.1023/A:1020514925143 (Pubitemid 35252485)
82. Uehara M., Kinoshita T., Hojo T., Akashi-Tanaka S., Iwamoto E., Fukutomi T., Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer. International Journal of Clinical Oncology 2008 13 5 447 451 2-s2.0-54849429384 10.1007/s10147-008-0773-3
83. Lauro S., Trasatti L., Bordin F., Lanzetta G., Bria E., Gelibter A., Gabriella Reale M., Vecchione A., Comparison of CEA, MCA, CA 15-3 and CA 27-29 in follow-up and monitoring therapeutic response in breast cancer patients. Anticancer Research 1999 19 4 3511 3515 2-s2.0-0033453299 (Pubitemid 30000212)
84. Marrelli D., Pinto E., de Stefano A., de Manzoni G., Farnetani M., Garosi L., Roviello F., Preoperative positivity of serum tumor markers is a strong predictor of hematogenous recurrence of gastric cancer. Journal of Surgical Oncology 2001 78 4 253 258 2-s2.0-0035185833 10.1002/jso.1163 (Pubitemid 33097056)
85. Carpelan-Holmström M., Louhimo J., Stenman U. H., Alfthan H., Järvinen H., Haglund C., Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology 2004 66 4 296 302 2-s2.0-3042594272 10.1159/000078330 (Pubitemid 38822799)
86. Mazal D., Lo-Man R., Bay S., Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer. Cancer Immunology, Immunotherapy 2013 62 6 1107 1122 10.1007/s00262-013-1425-7
87. Louhimo J., Kokkola A., Alfthan H., Stenman U., Haglund C., Preoperative hCG β and CA 72-4 are prognostic factors in gastric cancer. International Journal of Cancer 2004 111 6 929 933 2-s2.0-4143112573 10.1002/ijc.20321 (Pubitemid 39096242)
88. Louhimo J., Alfthan H., Stenman U. H., Haglund C., Serum HCG β and CA 72-4 are stronger prognostic factors than CEA, CA 19-9 and CA 242 in pancreatic cancer. Oncology 2004 66 2 126 131 2-s2.0-2342485639 10.1159/000077438 (Pubitemid 38608379)
89. Lee K. J., Yi S. W., Chung M. J., Park S. W., Song S. Y., Chung J. B., Park J. Y., Serum CA 19-9 and CEA levels as a prognostic factor in pancreatic adenocarcinoma. Yonsei Medical Journal 2013 54 3 643 649 10.3349/ymj.2013.54.3. 643
90. Haas M., Heinemann V., Kullmann F., Laubender R. P., Klose C., Bruns C. J., Holdenrieder S., Modest D. P., Schulz C., Boeck S., Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy. Journal of Cancer Research and Clinical Oncology 2013 139 4 681 689 10.1007/s00432-012-1371-3
91. Grunnet M., Sorensen J. B., Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer 2012 76 2 138 143 2-s2.0-84859435256 10.1016/j.lungcan.2011.11.012
92. Ilantzis C., Demarte L., Screaton R. A., Stanners C. P., Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. Neoplasia 2002 4 2 151 163 2-s2.0-0036118491 10.1038/sj/neo/7900201 (Pubitemid 34218683)
93. Sanders D. S. A., Kerr M. A., Lewis blood group and CEA related antigens; coexpressed cell-cell adhesion molecules with roles in the biological progression and dissemination of tumours. Journal of Clinical Pathology-Molecular Pathology 1999 52 4 174 178 2-s2.0-0032804389 (Pubitemid 29369201)
94. Fletcher R. H., Carcinoembryonic antigen. Annals of Internal Medicine 1986 104 1 66 73 2-s2.0-0022657730 (Pubitemid 16182780)
95. Goldstein M. J., Mitchell E. P., Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Investigation 2005 23 4 338 351 2-s2.0-24744451447 10.1081/CNV-58878 (Pubitemid 41656973)
96. Bakalakos E. A., Burak W. E. Jr., Young D. C., Martin E. W. Jr., Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases. The American Journal of Surgery 1999 177 1 2 6 2-s2.0-0033036765 10.1016/S0002-9610(98)00303-1 (Pubitemid 29088988)
97. Carlsson S. R., Fukuda M., Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes. The Journal of Biological Chemistry 1986 261 27 12779 12786 2-s2.0-0022996824 (Pubitemid 17204241)
98. Fukuda M., Carlsson S. R., Leukosialin, a major sialoglycoprotein on human leukocytes as differentiation antigens. Medical Biology 1986 64 6 335 343 2-s2.0-0022889757 (Pubitemid 17226776)
99. Remold-O'Donnell E., Zimmerman C., Kenney D., Rosen F. S., Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome. Blood 1987 70 1 104 109 2-s2.0-0023275895 (Pubitemid 17111248)
100. Wiken M., Bjorck P., Axelsson B., Perlmann P., Induction of CD43 expression during activation and terminal differentiation of human B cells. Scandinavian Journal of Immunology 1988 28 4 457 464 2-s2.0-0024259755 (Pubitemid 19005307)
101. Fukuda M., Leukosialin, a major O-glycan-containing sialoglycoprotein defining leukocyte differentiation and malignancy. Glycobiology 1991 1 4 347 356 2-s2.0-0025937004
102. Moore T., Huang S., Terstappen L. W. M. M., Bennett M., Kumar V., Expression of CD43 on murine and human pluripotent hematopoietic stem cells. Journal of Immunology 1994 153 11 4978 4987 2-s2.0-0027996207 (Pubitemid 24356129)
103. Hardy R. R., Carmack C. E., Shinton S. A., Kemp J. D., Hayakawa K., Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. Journal of Experimental Medicine 1991 173 5 1213 1225 2-s2.0-0025868702
104. Shelley C. S., Remold-O'Donnell E., Davis A. E. III, Bruns G. A. P., Rosen F. S., Carroll M. C., Whitehead A. S., Molecular characterization of sialophorin (CD43), the lymphocyte surface sialoglycoprotein defective in Wiskott-Aldrich syndrome. Proceedings of the National Academy of Sciences of the United States of America 1989 86 8 2819 2823 2-s2.0-0344475003 (Pubitemid 19112631)
105. Pallant A., Eskenazi A., Mattei M. G., Fournier R. E. K., Carlsson S. R., Fukuda M., Frelinger J. G., Characterization of cDNAs encoding human leukosialin and localization of the leukosialin gene to chromosome 16. Proceedings of the National Academy of Sciences of the United States of America 1989 86 4 1328 1332 2-s2.0-0345206200 (Pubitemid 19061539)
106. Cyster J. G., Shotton D. M., Williams A. F., The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO Journal 1991 10 4 893 902 2-s2.0-0026021936 (Pubitemid 21905547)
107. Cyster J., Somoza C., Killeen N., Williams A. F., Protein sequence and gene structure for mouse leukosialin (CD43), a T lymphocyte mucin without introns in the coding sequence. European Journal of Immunology 1990 20 4 875 881 2-s2.0-0025330551 10.1002/eji.1830200424 (Pubitemid 20167045)
108. Carlsson S. R., Sasaki H., Fukuda M., Structural variations of O-linked oligosaccharides present in leukosialin isolated from erythroid, myeloid, and T-lymphoid cell lines. The Journal of Biological Chemistry 1986 261 27 12787 12795 2-s2.0-0023019597 (Pubitemid 17204242)
109. Fukuda M., Tsuboi S., Mucin-type O-glycans and leukosialin. Biochimica et Biophysica Acta 1999 1455 2-3 205 217 2-s2.0-0032872724 10.1016/S0925-4439(99) 00067-8 (Pubitemid 29435989)
110. Remold-O'Donnell E., Kenney D., Rosen F. S., Biosynthesis of human sialophorins and analysis of the polypeptide core. Biochemistry 1987 26 13 3908 3913 2-s2.0-0023268190 (Pubitemid 17127460)
111. Brown T. J., Shuford W. W., Wang W. C., Nadler S. G., Bailey T. S., Marquardt H., Mittler R. S., Characterization of a CD43/leukosialin-mediated pathway for inducing apoptosis in human T-lymphoblastoid cells. The Journal of Biological Chemistry 1996 271 44 27686 27695 2-s2.0-0029959827 10.1074/jbc.271.44.27686 (Pubitemid 26367338)
112. Maemura K., Fukuda M., Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans. The Journal of Biological Chemistry 1992 267 34 24379 24386 2-s2.0-0026489530
113. Pedraza-Alva G., Rosenstein Y., CD43-one molecule, many tales to recount. Signal Transduction 2007 7 5-6 372 385 2-s2.0-38749126436 10.1002/sita. 200700140 (Pubitemid 351182183)
114. Ostberg J. R., Barth R. K., Frelinger J. G., The Roman god Janus: a paradigm for the function of CD43. Immunology Today 1998 19 12 546 550 2-s2.0-0031764539 10.1016/S0167-5699(98)01343-7 (Pubitemid 28557116)
115. Schmid K., Hediger M. A., Brossmer R., Collins J. H., Haupt H., Marti T., Offner G. D., Schaller J., Takagaki K., Walsh M. T., Schwick H. G., Rosen F. S., O'Donnell E. R., Amino acid sequence of human plasma galactoglycoprotein: identity with the extracellular region of CD43 (sialophorin). Proceedings of the National Academy of Sciences of the United States of America 1992 89 2 663 667 2-s2.0-0026584818
116. Bazil V., Strominger J. L., CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes. Proceedings of the National Academy of Sciences of the United States of America 1993 90 9 3792 3796 2-s2.0-0027322125 (Pubitemid 23134111)
117. Bažil V., Strominger J. L., Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes: induction of cleavage of L-selectin via CD16. Journal of Immunology 1994 152 3 1314 1322 2-s2.0-0028265826 (Pubitemid 24134359)
118. Remold-O'Donnell E., Parent D., Two proteolytic pathways for down-regulation of the barrier molecule CD43 of human neutrophils. Journal of Immunology 1994 152 7 3595 3605 2-s2.0-0028258922 (Pubitemid 24098057)
119. Yonemura S., Hirao M., Doi Y., Takahashi N., Kondo T., Tsukita S., Tsukita S., Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. Journal of Cell Biology 1998 140 4 885 895 2-s2.0-0032559637 10.1083/jcb.140.4.885 (Pubitemid 28141226)
120. Cruz-Muñoz M. E., Salas-Vidal E., Salaiza-Suazo N., Becker I., Pedraza-Alva G., Rosenstein Y., The CD43 coreceptor molecule recruits the ζ -chain as part of its signaling pathway. Journal of Immunology 2003 171 4 1901 1908 2-s2.0-18744433557 (Pubitemid 36966473)
121. Yonemura S., Nagafuchi A., Sato N., Tsukita S., Concentration of an integral membrane protein, CD43 (leukosialin, sialophorin), in the cleavage furrow through the interaction of its cytoplasmic domain with actin-based cytoskeletons. Journal of Cell Biology 1993 120 2 437 449 2-s2.0-0027509048 10.1083/jcb.120.2.437 (Pubitemid 23040082)
122. Pedraza-Alva G., Mérida L. B., Burakoff S. J., Rosenstein Y., T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation. The Journal of Biological Chemistry 1998 273 23 14218 14224 2-s2.0-0032486271 10.1074/jbc.273.23.14218 (Pubitemid 28319133)
123. Allenspach E. J., Cullinan P., Tong J., Tang Q., Tesciuba A. G., Cannon J. L., Takahashi S. M., Morgan R., Burkhardt J. K., Sperling A. I., ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse. Immunity 2001 15 5 739 750 2-s2.0-18244364886 10.1016/S1074-7613(01)00224-2 (Pubitemid 34008502)
124. Vodyanik M. A., Thomson J. A., Slukvin I. I., Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 2006 108 6 2095 2105 2-s2.0-33748699110 10.1182/blood-2006-02-003327 (Pubitemid 44395026)
125. Rosenstein Y., Santana A., Pedraza-Alva G., CD43, a molecule with multiple functions. Immunologic Research 1999 20 2 89 99 2-s2.0-0032696212
126. Fuhlbrigge R. C., King S. L., Sackstein R., Kupper T. S., CD43 is a ligand for E-selectin on CLA+ human T cells. Blood 2006 107 4 1421 1426 2-s2.0-32644433827 10.1182/blood-2005-05-2112 (Pubitemid 43242377)
127. Matsumoto M., Atarashi K., Umemoto E., Furukawa Y., Shigeta A., Miyasaka M., Hirata T., CD43 functions as a ligand for E-selectin on activated T cells. Journal of Immunology 2005 175 12 8042 8050 2-s2.0-29144443563 (Pubitemid 41798366)
128. Yang R. Y., Rabinovich G. A., Liu F. T., Galectins: structure, function and therapeutic potential. Expert Reviews in Molecular Medicine 2008 10 article e17 10.1017/S1462399408000719 (Pubitemid 351850788)
129. van den Berg T. K., Nath D., Ziltener H. J., Vestweber D., Fukuda M., van Die I., Crocker P. R., Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1). Journal of Immunology 2001 166 6 3637 3640 2-s2.0-0035869317 (Pubitemid 32224881)
130. Moreno-Amaral A. N., Gout E., Danella-Polli C., Tabarin F., Lesavre P., Pereira-da-Silva G., Thielens N. M., Halbwachs-Mecarelli L., M-ficolin and leukosialin (CD43): new partners in neutrophil adhesion. Journal of Leukocyte Biology 2012 91 3 469 474 2-s2.0-84857853838 10.1189/jlb.0911460
131. Sanchez-Mateos P., Campanero M. R., del Pozo M. A., Sanchez-Madrid F., Regulatory role of CD43 leukosialin on integrin-mediated T-cell adhesion to endothelial and extracellular matrix ligands and its polar redistribution to a cellular uropod. Blood 1995 86 6 2228 2239 2-s2.0-0029161570
132. Hirano K., Miki Y., Hirai Y., Sato R., Itoh T., Hayashi A., Yamanaka M., Eda S., Beppu M., A multifunctional shuttling protein nucleolin is a macrophage receptor for apoptotic cells. The Journal of Biological Chemistry 2005 280 47 39284 39293 2-s2.0-28244478396 10.1074/jbc.M505275200 (Pubitemid 41713883)
133. Rosenstein Y., Park J. K., Hahn W. C., Rosen F. S., Bierer B. E., Burakoff S. J., CD43, a molecule defective in Wiskott-Aldrich syndrome, binds ICAM-1. Nature 1991 354 6350 233 235 2-s2.0-0025993873 10.1038/354233a0 (Pubitemid 21896822)
134. Walker J., Green J. M., Structural requirements for CD43 function. Journal of Immunology 1999 162 7 4109 4114 2-s2.0-0033120554 (Pubitemid 29314795)
135. Fiume G., Rossi A., de Laurentiis A., Falcone C., Pisano A., Vecchio E., Pontoriero M., Scala I., Scialdone A., Masci F. F., Mimmi S., Palmieri C., Scala G., Quinto I., Eukaryotic initiation factor 4H is under transcriptional control of p65/NF- κ B. PLoS ONE 2013 8 6 e66087 10.1371/journal.pone.0066087
136. Fiume G., Vecchio E., de Laurentiis A., Trimboli F., Palmieri C., Pisano A., Falcone C., Pontoriero M., Rossi A., Scialdone A., Masci F. F., Scala G., Quinto I., Human immunodeficiency virus-1 Tat activates NF- B via physical interaction with I B- α and p65. Nucleic Acids Research 2012 40 8 3548 3562 2-s2.0-84860371902 10.1093/nar/gkr1224
137. Andersson C. X., Fernandez-Rodriguez J., Laos S., Baeckström D., Haass C., Hansson G. C., Shedding and γ -secretase-mediated intramembrane proteolysis of the mucin-type molecule CD43. Biochemical Journal 2005 387 2 377 384 2-s2.0-17644421407 10.1042/BJ20041387 (Pubitemid 40571223)
138. Santana M. A., Pedraza-Alva G., Olivares-Zavaleta N., Madrid-Marina V., Horejsi V., Burakoff S. J., Rosenstein Y., CD43-mediated signals induce DNA binding activity of AP-1, NF-AT and NF B transcription factors in human T lymphocytes. The Journal of Biological Chemistry 2000 275 40 31460 31468 2-s2.0-0034613264
139. Baeckstrom D., Zhang K., Asker N., Ruetschi U., Ek M., Hansson G. C., Expression of the leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line. The Journal of Biological Chemistry 1995 270 23 13688 13692 2-s2.0-0029067525 10.1074/jbc.270.23.13688
140. Baeckström D., Post-translational fate of a mucin-like leukocyte sialoglycoprotein (CD43) aberrantly expressed in a colon carcinoma cell line. The Journal of Biological Chemistry 1997 272 17 11503 11509 2-s2.0-0030932972 (Pubitemid 27184160)
141. Fernandez-Rodriguez J., Andersson C. X., Laos S., Baeckström D., Sikut A., Sikut R., Hansson G. C., The leukocyte antigen CD43 is expressed in different cell lines of nonhematopoietic origin. Tumor Biology 2002 23 4 193 201 2-s2.0-0036948240 10.1159/000067252 (Pubitemid 36091914)
142. Ziprin P., Alkhamesi N. A., Ridgway P. F., Peck D. H., Darzi A. W., Tumour-expressed CD43 (sialophorin) mediates tumour-mesothelial cell adhesion. Biological Chemistry 2004 385 8 755 761 2-s2.0-4544276997 10.1515/BC.2004.092 (Pubitemid 39255634)
143. Pimenidou A., Madden L. A., Topping K. P., Smith K. A., Monson J. R. T., Greenman J., Novel CD43 specific phage antibodies react with early stage colorectal tumours. Oncology Reports 2004 11 2 327 331 2-s2.0-3242749983
144. Santamaría M., López-Beltrán A., Toro M., Peña J., Molina I. J., Specific monoclonal antibodies against leukocyte-restricted cell surface molecule CD43 react with nonhematopoietic tumor cells. Cancer Research 1996 56 15 3526 3529 2-s2.0-0030015134 (Pubitemid 26251647)
145. Sikut R., Nilsson O., Baeckström D., Hansson G. C., Colon adenoma and cancer cells aberrantly express the leukocyte-associated sialoglycoprotein CD43. Biochemical and Biophysical Research Communications 1997 238 2 612 616 2-s2.0-0031577561 10.1006/bbrc.1997.7334 (Pubitemid 27464437)
146. Fu Q., Cash S. E., Andersen J. J., Kennedy C. R., Oldenburg D. G., Zander V. B., Foley G. R., Simon Shelley C., CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target. International Journal of Cancer 2013 132 8 1761 1770 10.1002/ijc.27873
147. de Laurentiis A., Gaspari M., Palmieri C., Falcone C., Iaccino E., Fiume G., Massa O., Masullo M., Tuccillo F. M., Roveda L., Prati U., Fierro O., Cozzolino I., Troncone G., Tassone P., Scala G., Quinto I., Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein. Molecular and Cellular Proteomics 2011 10 5 M111.007898 2-s2.0-79955750270 10.1074/mcp.M111.007898
148. Lefebvre J., Giordanengo V., Limouse M., Doglio A., Cucchiarini M., Monpoux F., Mariani R., Peyron J., Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line. Journal of Experimental Medicine 1994 180 5 1609 1617 2-s2.0-0027943181 10.1084/jem.180.5.1609 (Pubitemid 24328553)
149. Khan S., Holding S., Doré P. C., Sewell W. A. C., Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome. Medical Hypotheses 2008 70 2 269 272 2-s2.0-37349049916 10.1016/j.mehy.2007.05.048 (Pubitemid 350297629)
150. Sikut R., Andersson C. X., Sikut A., Fernandez-Rodriguez J., Karlsson N. G., Hansson G. C., Detection of CD43 (leukosialin) in colon adenoma and adenocarcinoma by novel monoclonal antibodies against its intracellular domain. International Journal of Cancer 1999 82 1 52 58 10.1002/(SICI)1097- 0215(19990702)82:1<52::AID-IJC10>3.0.CO;2-C (Pubitemid 29266106)
151. Fernandez-Rodriguez J., Dwir O., Alon R., Hansson G. C., Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions. Glycoconjugate Journal 2001 18 11-12 925 930 2-s2.0-0035526270 10.1023/A:1022208727512 (Pubitemid 36315057)
152. Shimodaira K., Nakayama J., Nakamura N., Hasebe O., Katsuyama T., Fukuda M., Carcinoma-associated expression of core 2 β -1,6-N- acetylglucosaminlytransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Research 1997 57 23 5201 5206 2-s2.0-0030658888 (Pubitemid 27516348)
153. Petretti T., Kemmner W., Schulze B., Schlag P. M., Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases. Gut 2000 46 3 359 366 2-s2.0-0034021674 10.1136/gut.46.3.359 (Pubitemid 30313387)
154. Kojima N., Handa K., Newman W., Hakomori S., Inhibition of selectin-dependent tumor cell adhesion to endothelial cells and platelets by blocking O-glycosylation of these cells. Biochemical and Biophysical Research Communications 1992 182 3 1288 1295 2-s2.0-0026562067
155. Sawada R., Tsuboi S., Fukuda M., Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer exhibiting distinct metastatic potentials. The Journal of Biological Chemistry 1994 269 2 1425 1431 2-s2.0-0028044784 (Pubitemid 24032540)
156. Martín-Satué M., Marrugat R., Cancelas J. A., Blanco J., Enhanced expression of α (1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. Cancer Research 1998 58 7 1544 1550 2-s2.0-2542546681 (Pubitemid 28193622)
157. Seo W., Ziltener H. J., CD43 processing and nuclear translocation of CD43 cytoplasmic tail are required for cell homeostasis. Blood 2009 114 17 3567 3577 2-s2.0-70449493989 10.1182/blood-2009-06-228791
158. Andersson C. X., Fernandez-Rodriguez J., Laos S., Sikut R., Sikut A., Baeckström D., Hansson G. C., CD43 has a functional NLS, interacts with β -catenin, and affects gene expression. Biochemical and Biophysical Research Communications 2004 316 1 12 17 2-s2.0-1542375465 10.1016/j.bbrc.2004. 02.011 (Pubitemid 38299121)
159. Tassone P., Bond H., Bonelli P., Tuccillo F., Ualerio G., Petrella A., Lamberti A., Cecco L., Turco M. C., Cerra M., Montagnani S., Morrone G., Venuta S., UN1, a murine monoclonal antibody recognizing a novel human thymic antigen. Tissue Antigens 1994 44 2 73 82 2-s2.0-0027991858 (Pubitemid 24262459)
160. Cecco L., Bond H. M., Bonelli P., Tuccillo F., Cerra M., Tassone P., Sorice R., Lamberti A., Morrone G., Venuta S., Purification and characterization of a human sialoglycoprotein antigen expressed in immature thymocytes and fetal tissues. Tissue Antigens 1998 51 5 528 535 2-s2.0-15444347038 (Pubitemid 28269222)
161. de Laurentiis A., Caterino M., Orrù S., Ruoppolo M., Tuccillo F., Masullo M., Quinto I., Scala G., Pucci P., Palmieri C., Tassone P., Salvatore F., Venuta S., Partial purification and MALDI-TOF MS analysis of UN1, a tumor antigen membrane glycoprotein. International Journal of Biological Macromolecules 2006 39 1-3 122 126 2-s2.0-33746319359 10.1016/j.ijbiomac.2006. 02.020 (Pubitemid 44102696)
162. Okumura K., Kato K., Kobata T., Kishimoto T., Kikutani H., von dem Borne A. E. G. K., Goyert S. M., Mason D. Y., Miyasaka M., Moretta L., Okumura K., Shaw S., Springer T. A., Sugamura K., Zola H., T-cell antigens: section report. Leukocyte Typing VI: White Cell Differentiation Antigens 1998 Garland Publishing 23 32
163. Boumsell L., Schlossman S. F., Boumsell L., Gilks W., Harlan J. M., Kishimoto T., Morimoto T., Ritz J., Shaw S., Silverstein R., Springer T., Tedder T. F., Todd R. F., T-cell antigens: section report. Leukocyte Typing V: White Cell Differentiation Antigens 1995 New York, NY, USA Oxford University Press 241 279
164. Tassone P., Tuccillo F., Bonelli P., D'Armiento F. P., Bond H. M., Palmieri C., Tagliaferri P., Venuta S., Fetal ontogeny and tumor expression of the early thymic antigen UN1. International Journal of Oncology 2002 20 4 707 711 2-s2.0-0036550631
165. Tassone P., Bonelli P., Tuccillo F., Bond H. M., D'Armiento F. P., Galea E., Palmieri C., Tagliaferri P., Natali P. G., Venuta S., Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomas. Anticancer Research 2002 22 4 2333 2340 2-s2.0-0036331941 (Pubitemid 34857062)